Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital of Erlangen, Erlangen, Germany.
Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic.
Mod Pathol. 2021 Aug;34(8):1507-1520. doi: 10.1038/s41379-021-00789-8. Epub 2021 Mar 19.
Giant cell tumors of soft tissue (GCT-ST) are rare low-grade neoplasms that were at one time thought to represent the soft tissue counterparts of GCT of bone (GCT-B) but are now known to lack the H3F3 mutations characteristic of osseous GCT. We present six distinctive giant cell-rich soft tissue neoplasms that expressed keratins and carried a recurrent HMGA2-NCOR2 gene fusion. Patients were five females and one male aged 14-60 years (median, 29). All presented with superficial (subcutaneous) masses that were removed by conservative marginal (3) or wide (2) local excision. The tumors originated in the upper extremity (2), lower extremity (2), head/neck (1), and trunk (1). Five patients with follow-up (median, 21 months; range, 14-168) remained disease-free. Grossly, all tumors were well-demarcated but not encapsulated with variable lobulation. Histologically, they were composed of bland plump epithelioid or ovoid to spindled mononuclear cells admixed with evenly distributed multinucleated osteoclast-type giant cells. Foci of stromal hemorrhage and hemosiderin were seen in all cases. The mitotic activity ranged from 2 to 14/10 high power fields (median: 10). Foci of necrosis and vascular invasion were seen in one case each. The mononuclear cells were immunoreactive with the AE1/AE3 keratin cocktail and less frequently/less diffusely for K7 and K19 but lacked expression of other lineage-associated markers. RNA-based next-generation sequencing revealed an HMGA2-NCOR2 fusion in all tumors. None of the keratin-negative conventional GCT-ST showed the HMGA2-NCOR2 fusion (0/7). Metaplastic bone (4/9) and SATB2 expression (3/4) were frequent in keratin-negative conventional GCT-ST but were lacking in keratin-positive HMGA2-NCOR2 fusion-positive tumors. The distinctive immunophenotype and genotype of these tumors strongly suggest that they represent a discrete entity, differing from conventional GCT-ST and other osteoclast-rich morphologic mimics. Their natural history appears favorable, although a study of additional cases and longer follow-up are warranted.
软组织巨细胞瘤(GCT-ST)是一种罕见的低级肿瘤,曾经被认为是骨巨细胞瘤(GCT-B)的软组织对应物,但现在已知缺乏骨巨细胞瘤特有的 H3F3 突变。我们提出了六个独特的富含巨细胞的软组织肿瘤,这些肿瘤表达角蛋白,并携带反复出现的 HMGA2-NCOR2 基因融合。患者为 5 名女性和 1 名男性,年龄 14-60 岁(中位数 29 岁)。所有患者均表现为浅表(皮下)肿块,通过保守性边缘(3 例)或广泛(2 例)局部切除切除。肿瘤起源于上肢(2 例)、下肢(2 例)、头颈部(1 例)和躯干(1 例)。5 例有随访(中位数 21 个月;范围 14-168 个月)的患者无疾病。大体上,所有肿瘤界限清楚,但无包膜,呈不同程度的分叶状。组织学上,它们由温和的肥胖上皮样或卵圆形至梭形单核细胞组成,混合均匀分布的多核破骨细胞样巨细胞。所有病例均可见间质出血和含铁血黄素沉积。核分裂象活性范围为 2-14/10 高倍视野(中位数:10)。各有 1 例肿瘤可见坏死和血管侵犯灶。单核细胞对 AE1/AE3 角蛋白鸡尾酒呈免疫反应性,较少/较少弥漫性地表达 K7 和 K19,但缺乏其他谱系相关标志物的表达。基于 RNA 的下一代测序显示所有肿瘤均存在 HMGA2-NCOR2 融合。无角蛋白阴性的传统 GCT-ST 显示 HMGA2-NCOR2 融合(0/7)。角蛋白阴性的传统 GCT-ST 中常可见骨转换(4/9)和 SATB2 表达(3/4),但在角蛋白阳性的 HMGA2-NCOR2 融合阳性肿瘤中则无。这些肿瘤独特的免疫表型和基因型强烈提示它们代表一种独特的实体,与传统的 GCT-ST 和其他破骨细胞丰富的形态模拟物不同。它们的自然病程似乎良好,但需要进一步研究更多病例和更长时间的随访。